Parcopa Versus Carbidopa-levodopa in a Single Dose Cross-over Comparison Study

NCT00590122 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Parcopa
DRUG: carbidopa-levodopa (Sinemet)

Sponsor

Baylor College of Medicine

Collaborators

[object Object]